These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 111104)

  • 1. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human placental lactogen (HPL) levels in the maternal serum following long-term intake of xantinol nicotinate (Complamin Retard) (author's transl)].
    Sérey CT; Saling E
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):283-9. PubMed ID: 7008399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the oxidative glucose brain metabolism under long-term xantinol-nicotinate medication (author's transl)].
    Quadbeck H; Lehmann E
    Arzneimittelforschung; 1978; 28(9):1531-2. PubMed ID: 582552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B; Molnár L; Demeter J; Túry F
    Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Learning and concentration abilities of elderly patients with the depressive syndrome in cerebrovascular circulation disorders].
    Haupt R; Isermann H
    Nervenarzt; 1976 Apr; 47(4):269-71. PubMed ID: 1272488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 9. [The computerized electroencephalogram in evaluating the action of vasoactive and eumetabolic drugs in chronic cerebrovascular disorders].
    Martucci N; Bocola V; Mearelli S; Agnoli A
    Riv Neurol; 1980; 50(2):73-97. PubMed ID: 6110238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapy of tinnitus resulting from blast injury (author's transl)].
    Jakobs P; Martin G
    HNO; 1978 Mar; 26(3):104-6. PubMed ID: 346541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation and structure determination of metabolites of xantinol from rat urine (author's transl)].
    Tauscher M; Eckhardt G; Geisel B; Credner K
    Arzneimittelforschung; 1976; 26(7):1342-4. PubMed ID: 1036921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xantinol nicotinate in paralytic poliomyelitis.
    Saksena PN; Malik GK; Tandon OP
    Indian Pediatr; 1979 Dec; 16(12):1081-4. PubMed ID: 541073
    [No Abstract]   [Full Text] [Related]  

  • 15. Xanthinol nicotinate in the management of leg ulcers associated with haemoglobinopathies.
    Afifi AM; Adnan M; Taha M; Amasha ME
    Curr Med Res Opin; 1979; 6(5):309-13. PubMed ID: 540521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulatory effects of xanthinol nicotinate in advanced pregnancy (author's transl)].
    Schwarz R; Retzke U; Lauckner W
    Zentralbl Gynakol; 1980; 102(8):446-51. PubMed ID: 7456902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication.
    Haacke H; Parwaresch MR; Mäder C
    Atherosclerosis; 1980 Sep; 37(1):77-85. PubMed ID: 7426090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of complamin and seduxen in the correction of hemodynamic disorders of epileptic children and adolescents].
    Bulakhova LA; Martyniuk VIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(6):858-62. PubMed ID: 3630497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD
    Med Monatsschr; 1976 Apr; 30(4):178-80. PubMed ID: 958145
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR; Kogel H
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.